You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients

Article info

Article menu

Download PDFPDF

Case Report
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients

Authors

  • Michael T. Tetzlaff Department of Pathology, Section of DermatopathologyThe University of Texas MD Anderson Cancer Center Houston TX USA Department of Translational and Molecular PathologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Kelly C. Nelson Department of DermatologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Adi Diab Department of Melanoma Medical OncologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Gregg A. Staerkel Department of Pathology, Section of CytopathologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Priyadharsini Nagarajan Department of Pathology, Section of DermatopathologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Carlos A. Torres-Cabala Department of Pathology, Section of DermatopathologyThe University of Texas MD Anderson Cancer Center Houston TX USA Department of DermatologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Beth A. Chasen Department of Nuclear MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Jennifer A. Wargo Department of Surgical OncologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Victor G. Prieto Department of Pathology, Section of DermatopathologyThe University of Texas MD Anderson Cancer Center Houston TX USA Department of DermatologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Rodabe N. Amaria Department of Melanoma Medical OncologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Jonathan L. Curry Department of Pathology, Section of DermatopathologyThe University of Texas MD Anderson Cancer Center Houston TX USA Department of DermatologyThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  1. ↵k jlcurry{at}mdanderson.org
View Full Text

Citation

Tetzlaff MT, Nelson KC, Diab A, et al
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients
Journal for ImmunoTherapy of Cancer 2018;6:14. doi: 10.1186/s40425-018-0323-0

Publication history

  • Received October 28, 2017
  • Accepted January 26, 2018
  • First published February 12, 2018.
Online issue publication 
February 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.